Trexquant Investment’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Sell |
223,121
-410,504
| -65% | -$3.74M | 0.02% | 878 |
|
|
2025
Q1 | $5.04M | Buy |
633,625
+488,963
| +338% | +$3.89M | 0.06% | 500 |
|
|
2024
Q4 | $786K | Sell |
144,662
-30,999
| -18% | -$168K | 0.01% | 1174 |
|
|
2024
Q3 | $1.27M | Sell |
175,661
-139,582
| -44% | -$1.01M | 0.02% | 968 |
|
|
2024
Q2 | $3.42M | Buy |
315,243
+287,385
| +1,032% | +$3.12M | 0.05% | 534 |
|
|
2024
Q1 | $522K | Sell |
27,858
-75,239
| -73% | -$1.41M | 0.01% | 1130 |
|
|
2023
Q4 | $2.23M | Buy |
+103,097
| New | +$2.23M | 0.05% | 513 |
|
|
2023
Q1 | – | Sell |
-20,249
| Closed | -$772K | – | 1726 |
|
|
2022
Q4 | $772K | Sell |
20,249
-1,345
| -6% | -$51.3K | 0.02% | 750 |
|
|
2022
Q3 | $846K | Buy |
+21,594
| New | +$846K | 0.03% | 591 |
|
|
2022
Q1 | – | Sell |
-6,599
| Closed | -$281K | – | 1672 |
|
|
2021
Q4 | $281K | Buy |
+6,599
| New | +$281K | 0.02% | 959 |
|
|
2020
Q2 | – | Sell |
-24,897
| Closed | -$715K | – | 1432 |
|
|
2020
Q1 | $715K | Buy |
+24,897
| New | +$715K | 0.05% | 526 |
|
|
2019
Q1 | – | Sell |
-2,164
| Closed | -$207K | – | 1278 |
|
|
2018
Q4 | $207K | Sell |
2,164
-1,359
| -39% | -$130K | 0.01% | 906 |
|
|
2018
Q3 | $498K | Sell |
3,523
-16,682
| -83% | -$2.36M | 0.04% | 539 |
|
|
2018
Q2 | $3.16M | Buy |
+20,205
| New | +$3.16M | 0.22% | 155 |
|
|
2017
Q2 | – | Sell |
-6,108
| Closed | -$434K | – | 1120 |
|
|
2017
Q1 | $434K | Sell |
6,108
-3,792
| -38% | -$269K | 0.06% | 595 |
|
|
2016
Q4 | $505K | Sell |
9,900
-7,900
| -44% | -$403K | 0.08% | 429 |
|
|
2016
Q3 | $820K | Buy |
+17,800
| New | +$820K | 0.18% | 166 |
|
|
2015
Q2 | – | Sell |
-25,815
| Closed | -$1.3M | – | 1206 |
|
|
2015
Q1 | $1.3M | Buy |
+25,815
| New | +$1.3M | 0.13% | 261 |
|